Search results
Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market By Investing.com
Investing.com· 2 days agoVerona Pharma (NASDAQ:VRNA) has announced its first quarter 2024 financial results, highlighting the...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 2 days agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Verona...
Benzinga· 3 days agoPDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT /
Pulmonary Function Test
Health via Yahoo News· 3 days agoHealthcare providers use PFTs to: Diagnose lung conditions, such as COPD, asthma, emphysema (a form of COPD characterized by damage to the lungs' air...
Yupelri Dosage: Form, Strength, How To Use, and More
Healthline· 5 days agoYupelri (revefenacin) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a liquid solution for inhalation with a jet ...
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
GuruFocus.com via Yahoo Finance· 2 days agoThis product is poised to be the first new inhaled treatment mechanism for Chronic Obstructive Pulmonary Disease (COPD) in over two decades, pending approval ...
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoInsmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript May 9, 2024 Insmed Incorporated...
What You Need to Know About Inhalants for Crohn's Disease
Healthline· 3 days agoInhaled corticosteroids aren’t a common treatment option for Crohn’s disease. Crohn’s disease (CD)...
Warner Bros. upgraded, Cerence downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 2 days agoBofA initiated coverage of Apogee Therapeutics (APGE) with a Buy rating and $80 price target. The...
Varenicline Leads in Helping Smokers Kick the Habit, Study
Medscape· 3 days agoMost smokers do successfully quit after their first attempt. Switching patients from nicotine...